Trials / Conditions / Gout and Hyperuricemia
Gout and Hyperuricemia
5 registered clinical trials studyying Gout and Hyperuricemia — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | SAVE-Care (Sodium Glucose Cotransporter-2 Inhibitors [SGLT2i] As Novel Gout Care) Trial NCT06674109 | Massachusetts General Hospital | Phase 4 |
| Not Yet Recruiting | Clinical Trial of BR2251 Tablets for Patients With Primary Gout and Hyperuricemia NCT07498647 | BioRay Pharmaceutical Co., Ltd. | Phase 2 |
| Not Yet Recruiting | HLA-B*58:01-Guided Therapy for Gout: Effectiveness, Safety, and Cost-Effectiveness NCT07369622 | Haiphong University of Medicine and Pharmacy | Phase 4 |
| Completed | PK Effects of SHR4640 on Repaglinide and Midazolam, and the Impact of SHR4640 on QT Interval NCT06196580 | Jiangsu HengRui Medicine Co., Ltd. | Phase 1 |
| Completed | Phase II Dose Finding Study of RDEA3170 Versus Placebo in Japanese Patients With Gout or Asymptomatic Hyperuri NCT02078219 | AstraZeneca | Phase 2 |